Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 141.17%411.2M | 75.06%158.6M | 51.70%214.5M | -55.36%740.1M | -44.19%337.6M | -44.10%170.5M | -81.49%90.6M | -45.36%141.4M | 155.29%1.66B | 96.91%604.9M |
| Net income from continuing operations | 911.76%68.8M | 226.39%23.5M | 2,128.38%150.1M | -128.61%-213M | -216.68%-219.6M | -89.22%6.8M | -97.87%7.2M | -104.79%-7.4M | -13.97%744.5M | -48.45%188.2M |
| Operating gains losses | -32.32%11.1M | 550.54%41.9M | -280.06%-126.4M | 1,950.00%209.1M | 235.74%131.8M | -88.36%16.4M | 87.92%-9.3M | 61.75%70.2M | -88.96%10.2M | -73.08%-97.1M |
| Depreciation and amortization | 7.68%117.8M | 5.61%113M | 2.70%106.5M | 9.17%427.6M | 4.27%107.5M | 8.86%109.4M | 11.81%107M | 12.23%103.7M | 26.19%391.7M | 14.56%103.1M |
| Asset impairment expenditure | ---- | ---- | ---- | 66.29%193.4M | ---- | ---- | ---- | ---- | --116.3M | ---- |
| Deferred tax | 9.56%27.5M | -432.98%-31.3M | -25.69%10.7M | -100.48%-1M | -223.51%-49.9M | -51.73%25.1M | -87.63%9.4M | -65.05%14.4M | -30.25%209.6M | -56.09%40.4M |
| Other non cashItems | -0.92%64.5M | -0.96%51.6M | -13.79%42.5M | -2.20%209.1M | -15.81%42.6M | -13.08%65.1M | 20.05%52.1M | 9.80%49.3M | 80.12%213.8M | 10.48%50.6M |
| Change In working capital | 413.51%132.3M | 19.55%-35.8M | 656.15%72.3M | -72.74%62.2M | -30.13%161.9M | 52.69%-42.2M | -146.60%-44.5M | -32.65%-13M | 133.11%228.2M | 243.91%231.7M |
| -Change in receivables | 20.68%-94M | -73.35%29.8M | -48.21%80.9M | 375.68%17.6M | 2.22%-131.9M | -115.85%-118.5M | -0.80%111.8M | 93.32%156.2M | 102.22%3.7M | -25.61%-134.9M |
| -Change in inventory | -475.60%-143.9M | 562.39%50.4M | 52.27%-8.4M | 119.25%268.8M | -19.14%322.3M | 87.26%-25M | -110.24%-10.9M | 90.54%-17.6M | 123.86%122.6M | 66.29%398.6M |
| -Change in payables and accrued expense | 176.82%377.3M | -31.83%-75.8M | 128.95%51.7M | -123.93%-215.2M | -70.71%-115.4M | 1.79%136.3M | 72.10%-57.5M | -508.70%-178.6M | 11.18%-96.1M | 80.08%-67.6M |
| -Change in other current assets | 44.05%-4.7M | 123.87%10M | ---7.8M | -68.82%-31.4M | 285.71%18.9M | -400.00%-8.4M | -60.54%-41.9M | --0 | -143.06%-18.6M | -54.63%4.9M |
| -Change in other current liabilities | 678.38%21.4M | 184.13%10.6M | 39.17%-7.3M | 74.93%-8.6M | 272.81%19.7M | 61.05%-3.7M | -229.90%-12.6M | 48.05%-12M | 81.32%-34.3M | 55.81%-11.4M |
| -Change in other working capital | -3.93%-23.8M | -82.04%-60.8M | -194.36%-36.8M | -87.64%31M | 14.73%48.3M | -165.80%-22.9M | -133.77%-33.4M | -48.07%39M | 4.76%250.9M | -30.98%42.1M |
| Tax refund paid | -6.93%-10.8M | 86.26%-4.3M | 45.65%-41.2M | 42.51%-147.3M | -6.36%-30.1M | 72.85%-10.1M | 62.24%-31.3M | 29.68%-75.8M | 26.51%-256.2M | 58.75%-28.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 141.17%411.2M | 75.06%158.6M | 51.70%214.5M | -55.36%740.1M | -44.19%337.6M | -44.10%170.5M | -81.49%90.6M | -45.36%141.4M | 155.29%1.66B | 96.91%604.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 34.46%-77.8M | 36.49%-67.7M | 30.63%-51.4M | 25.99%-425.5M | 43.30%-126.1M | 13.36%-118.7M | -6.71%-106.6M | 35.90%-74.1M | 32.63%-574.9M | 12.41%-222.4M |
| Net PPE purchase and sale | 36.68%-72M | 28.53%-70.4M | 32.49%-45.1M | 27.68%-396.6M | 45.38%-117.6M | 11.31%-113.7M | -5.12%-98.5M | 39.93%-66.8M | 8.75%-548.4M | 13.15%-215.3M |
| Net intangibles purchas and sale | -132.08%-12.3M | -26.76%-9M | -11.90%-9.4M | 20.32%-29.8M | 23.73%-9M | 47.52%-5.3M | 20.22%-7.1M | -27.27%-8.4M | 35.96%-37.4M | 21.33%-11.8M |
| Net business purchase and sale | --5.5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | 233.33%1M | -550.00%-6.5M | 181.82%3.1M | -91.74%900K | -89.36%500K | -76.92%300K | -137.04%-1M | -50.00%1.1M | -23.24%10.9M | -44.05%4.7M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 34.46%-77.8M | 36.49%-67.7M | 30.63%-51.4M | 25.99%-425.5M | 43.30%-126.1M | 13.36%-118.7M | -6.71%-106.6M | 35.90%-74.1M | 32.63%-574.9M | 12.41%-222.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -459.72%-359.9M | 63.58%-95.1M | 32.97%-78.9M | 30.58%-553.1M | 46.37%-110M | 72.75%-64.3M | -8.61%-261.1M | -2.08%-117.7M | -518.71%-796.8M | -286.96%-205.1M |
| Net issuance payments of debt | -15,842.11%-302.9M | -8.49%-39.6M | -8.29%-20.9M | 18.11%-108.5M | 18.20%-50.8M | 90.87%-1.9M | -22.48%-36.5M | 2.53%-19.3M | -120.00%-132.5M | -135.81%-62.1M |
| Net common stock issuance | 3,900.00%12M | 100.37%600K | --0 | 53.06%-200.9M | 100.78%600K | 100.19%300K | -5.91%-163M | 5.83%-38.8M | -45.23%-428M | -1,482.14%-77.4M |
| Cash dividends paid | -2.60%-15.8M | -2.61%-15.7M | 1.27%-15.6M | -11.33%-61.9M | -12.41%-15.4M | -11.59%-15.4M | -10.07%-15.3M | -11.27%-15.8M | -9.45%-55.6M | -8.73%-13.7M |
| Interest paid (cash flow from financing activities) | -10.76%-49.4M | 1.78%-44.1M | 4.12%-41.9M | -6.09%-177.8M | -7.21%-44.6M | -4.69%-44.6M | -5.40%-44.9M | -7.11%-43.7M | -66.43%-167.6M | -10.64%-41.6M |
| Net other financing activities | -40.74%-3.8M | 364.29%3.7M | -400.00%-500K | 69.47%-4M | 101.94%200K | 18.18%-2.7M | -600.00%-1.4M | -114.29%-100K | 49.81%-13.1M | 46.07%-10.3M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -459.72%-359.9M | 63.58%-95.1M | 32.97%-78.9M | 30.58%-553.1M | 46.37%-110M | 72.75%-64.3M | -8.61%-261.1M | -2.08%-117.7M | -518.71%-796.8M | -286.96%-205.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 64.21%271.6M | -25.18%312.3M | -63.40%180M | 143.10%491.8M | -48.62%145.7M | -57.43%165.4M | 95.96%417.4M | 143.10%491.8M | -23.89%202.3M | 373.46%283.6M |
| Current changes in cash | -112.00%-26.5M | 98.48%-4.2M | 267.06%84.2M | -183.28%-238.5M | -42.78%101.5M | 81.62%-12.5M | -285.85%-277.1M | -280.65%-50.4M | 2,205.88%286.4M | 8.83%177.4M |
| Effect of exchange rate changes | 169.44%5M | -245.42%-36.5M | 300.42%48.1M | -2,464.52%-73.3M | -318.18%-67.2M | 80.49%-7.2M | -4.92%25.1M | -39.53%-24M | 106.21%3.1M | 249.51%30.8M |
| End cash Position | 71.65%250.1M | 64.21%271.6M | -25.18%312.3M | -63.40%180M | -63.40%180M | -48.62%145.7M | -57.43%165.4M | 95.96%417.4M | 143.10%491.8M | 143.10%491.8M |
| Free cash from | 534.76%326.9M | 628.00%79.2M | 141.69%160M | -70.75%313.7M | -44.15%211M | -69.11%51.5M | -103.88%-15M | -53.05%66.2M | 10,931.31%1.07B | 752.82%377.8M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.